- Home
- ECL vs ZTS Comparison
ECL vs ZTS Comparison
Compare ECL & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECL
- ZTS
- Stock Information
- Founded
- ECL 1923
- ZTS 1952
- Country
- ECL United States
- ZTS United States
- Employees
- ECL N/A
- ZTS N/A
- Industry
- ECL Package Goods/Cosmetics
- ZTS Biotechnology: Pharmaceutical Preparations
- Sector
- ECL Consumer Discretionary
- ZTS Health Care
- Exchange
- ECL Nasdaq
- ZTS Nasdaq
- Market Cap
- ECL 76.2B
- ZTS 66.2B
- IPO Year
- ECL N/A
- ZTS 2013
- Fundamental
- Price
- ECL $276.51
- ZTS $146.42
- Analyst Decision
- ECL Buy
- ZTS Buy
- Analyst Count
- ECL 16
- ZTS 8
- Target Price
- ECL $291.87
- ZTS $200.25
- AVG Volume (30 Days)
- ECL 1.5M
- ZTS 3.1M
- Earning Date
- ECL 10-28-2025
- ZTS 11-04-2025
- Dividend Yield
- ECL 0.94%
- ZTS 1.37%
- EPS Growth
- ECL 25.59
- ZTS 14.10
- EPS
- ECL 7.48
- ZTS 5.82
- Revenue
- ECL $15,723,900,000.00
- ZTS $9,385,000,000.00
- Revenue This Year
- ECL $2.89
- ZTS $3.90
- Revenue Next Year
- ECL $5.59
- ZTS $5.92
- P/E Ratio
- ECL $36.96
- ZTS $25.17
- Revenue Growth
- ECL 0.57
- ZTS 5.27
- 52 Week Low
- ECL $221.62
- ZTS $139.34
- 52 Week High
- ECL $286.04
- ZTS $196.55
- Technical
- Relative Strength Index (RSI)
- ECL 58.27
- ZTS 46.66
- Support Level
- ECL $266.87
- ZTS $142.40
- Resistance Level
- ECL $275.22
- ZTS $149.54
- Average True Range (ATR)
- ECL 4.15
- ZTS 2.87
- MACD
- ECL 1.01
- ZTS 0.39
- Stochastic Oscillator
- ECL 86.34
- ZTS 69.41
About ECL Ecolab Inc.
Ecolab produces and markets cleaning and sanitation products for the industrial manufacturing, hospitality, healthcare, and life sciences markets. The firm is the global market share leader in this category with a wide array of products and services, including dish and laundry washing systems, pest control, and infection control products. Additionally, Ecolab sells customized water management solutions across its end markets. The company has a strong hold on the US market and is growing its presence abroad.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.